| ∧ ∨ Type | ∧ ∨ Title | Principal Investigators | Status | ∧ ∨ Year |
|---|---|---|---|---|
| Progetti PNRR - per il potenziamento di strutture di ricerca e creazioni di campioni nazionali di R&S |
National Center for Gene Therapy and Drugs based on RNA Technology
|
|
Ongoing | 2022 |
| PRIN2020 - PRIN bando 2020 |
New interventional approaches on multiple inflammatory pathways involved in regeneration after trauma and aging- associated diseases
|
|
Ongoing | 2022 |
| PRIN2020 - PRIN bando 2020 |
Role of TDP-43 self-assembly in health and disEase: molecular characteristics, cellular Aspects and animal Models
|
|
Ongoing | 2022 |
| PRIN2020 - PRIN bando 2020 |
Escaping the ESKAPEs: integrated pipelines for new antibacterial drugs
|
|
Ongoing | 2022 |
| INTLI - Finanziamenti internazionali |
Unveiling neuroplastic mechanisms in a periphery-to- brain crosstalk in an experimental model of anorexia nervosa
|
|
Closed | 2022 |
| Horizon Europe Global Challenge-RIA/IA/CSA |
Next generation advanced RNA inhibition therapy to treat cardiometabolic disease (LiverTarget)
|
|
Ongoing | 2022 |
| FON_NAZ - Bandi Altre Fondazioni |
A new role for exosomes in prostate cancer microenvironment: exploring the cross-talk between adipocytes and tumor cells (3° anno)
|
|
Ongoing | 2022 |
| Horizon Europe - Marie Skłodowska-Curie actions - Doctoral Networks (DN) |
Metal-containing Radical Enzymes (MetRaZymes)
|
|
Ongoing | 2022 |
| FON_NAZ - Bandi Altre Fondazioni |
Pharmacological block of the prokineticin system and of microglia activation to treat pain and mood disorders in Fabry-Anderson disease
|
|
Ongoing | 2022 |
| H20_RIA - Horizon 2020_Research & Innovation Action/Innovation Action |
The impact of early life stress in later life (EarlyCause)
|
|
Ongoing | 2022 |
